~~<i id='0111A2B11B'><strike id='0111A2B11B'><tt id='0111A2B11B'><pre id='0111A2B11B'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

focus

author：Wikipedia 2025-09-30 17:02:32 - browse：92934

AP/Richard Drew

Johnson & Johnson said Monday that it would purchase Ambrx Biopharma for nearly $2 billion, picking up a company specializing in targeted chemotherapy treatments — one of the hottest areas of cancer drug development.

The deal, disclosed as the biopharma field marked the first day of the annual J.P. Morgan Healthcare Conference, extends a recent spate of pharma acquisitions, contributing to hopes that 2024 could be a better year for the industry.

Under the agreement, J&J will pay $28 per share in cash for Ambrx, roughly a 100% premium to the latter’s recent trading price.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Physicians and social media: If you see something, say something?

knowledge

hotspot

Wikipedia

entertainment

knowledge

TheauthorpreachingatUnionBaptistChurchinBaltimore.CourtesyEvelynJ.ChatmonWhenIwasthepastorofalargeBa

WSS

Asbestos, a deadly carcinogen, banned by EPA

U.K. researchers warn about biases in medical devices, algorithms

Readout Newsletter: Geron, Novo Nordisk, WuXi updates

Medicare Advantage overpayments discussion gets experts fired up

Male doctors called my cancer incurable. A female doctor showed it wasn't

At JPM 2024, hospital systems pitch financial strength to investors

hotspot

focus

knowledge

Trump demands the U.S. pay no more for drugs than other countries … again

Methadone treatment changes are coming. Do they go far enough?

Malaria cases in Florida and Texas: Here’s what you need to know

Does Paxlovid work in people vaccinated against Covid

Hepatitis C has a cure — but many Americans still lack access to it

App could help diagnose ear infections more accurately — and at home

23andMe had bad news about my health. I wish a person had delivered it

Fauci's latest grilling in Congress: 9 hours, behind closed doors

Supreme Court strikes down use of affirmative action

Physicians and social media: If you see something, say something?

hotspot

U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

Ascension's ugly legal battle over care for poor patients in Texas

Physicians and social media: If you see something, say something?

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

Does Paxlovid work in people vaccinated against Covid

Plastic surgeons increase patient psychiatric screenings

Wikipedia

entertainment

entertainment

knowledge